2026
BiGMINT: Biologically-guided Hierarchical Multimodal Integration for Modeling Multiple Compound Activities in Drug Discovery
CVPR 2026
Compound activity modeling is critical for drug discovery, where accurate *in silico* predictions can significantly reduce reliance on expensive, time-consuming target-specific experimental assays. Traditional machine learning approaches for compound activity modeling typically rely on either chemop